Anemocyte is an Italian Biotech Manufacturing Organization with a strong focus on the development, manufacturing, and analytical services to address needs in the field of:
• pDNA – Plasmids manufacturing (R&D, Hiqh-Quality, and GMP) for Viral Vector and mRNA;
• mRNA – mRNA manufacturing (R&D) for vaccines and therapeutic treatments.
Our experience:
• More than 20 years of development and manufacturing experience (from R&D to GMP) in the field of Cell and Gene Therapies and Nucleic Acids.
• Over the years, Anemocyte has been involved in multiple projects with a wide range of complexity.
Company Details
- Employees
- 45
- Founded
- -
- Address
- Milano, Italia 20100, It
- Phone
- +39 02 99372311
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- anemocyte.com
- Keywords
- biotecnologie, biotechnology, atmp, cell & gene therapy, gmp, high quality, advanced therapy medicinal products, clinical trials, biotech, plasmidi, Biotech Manufacturing Organization, cdmo, plasmid, Contract Development and Manufacturing Organization, biotech organization, viral vectors, vettori virali, terapia genica, terapia cellulare, Good Manufacturing Practices, Cell Therapy, Gene Therapy, BMO, mRNA, pDNA.
- HQ
- Milano, italia
Anemocyte Questions
Anemocyte's helpline number is +39 02 99372311
Anemocyte's website is anemocyte.com
Anemocyte's LinkedIn profile is https://it.linkedin.com/company/anemocyte
Anemocyte has
45 employees.
View email and phone details for 45
employees at Anemocyte.
Anemocyte's industry is
Biotechnology Research
Anemocyte's top competitors are
Thermogenesis Holdings, Inc.,
Genenta Science (Nasdaq: Gnta),
Chiesi Group,
Molmed Now Part Of Agc Biologics,
Biorep,
Agc Biologics,
Dompé,
Axxam,
Generon S.p.a.,
Helixmith.
Anemocyte's categories are Biotechnology Research
Anemocyte's founding year is 2017
